Telehealth Anxiety Prescribing: What Psychiatrists Can Do

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe anxiety medications through telehealth — or trying to understand the regulatory landscape across state lines — you’re asking the right questions. The short answer: Yes, both MDs and NPs can prescribe anxiety meds via telehealth in 2026, but the specifics depend heavily on your provider type, your state license, and federal controlled substance rules.

Here’s what you actually need to know to practice confidently (and compliantly) in the current environment.

What Psychiatrists Can Do: Full Authority, Minimal Barriers

Let’s start with the straightforward part. If you’re a board-certified psychiatrist (MD or DO), your prescribing authority for anxiety medications via telehealth is essentially equivalent to in-person practice in all 50 states. You can:

• Conduct initial psychiatric evaluations remotely
• Diagnose anxiety disorders (GAD, panic disorder, social anxiety, etc.)
• Prescribe first-line treatments (SSRIs, SNRIs, buspirone)
• Prescribe controlled substances including benzodiazepines (Schedule IV)
• Manage medication adjustments and refills entirely online

The historical barrier — the Ryan Haight Act’s requirement for an in-person visit before prescribing controlled substances — remains suspended through December 2026. Federal agencies extended COVID-era telehealth flexibilities specifically to prevent millions of patients from losing access to medications like alprazolam, clonazepam, or stimulants for comorbid conditions. Over 7 million controlled substance prescriptions were written via telemedicine in 2024 alone under these rules.

What this means practically: You can start a new patient on Lexapro for generalized anxiety in a video visit. If they need short-term Xanax for panic attacks, you can prescribe that too — no in-person requirement. The DEA is working on permanent regulations (expected late 2026), but for now, telehealth prescribing of anxiety meds, including controlled substances, is fully permitted at the federal level.

State-Specific Telehealth Rules for Psychiatrists

While federal law opens the door, state laws add a few guardrails:

Florida explicitly permits teleprescribing of Schedule II controlled substances when treating psychiatric disorders. This carve-out was designed to ensure access to ADHD medications, but it covers any mental health treatment — meaning anxiety care is clearly in bounds. Florida does require you to check the state PDMP (E-FORCSE) before prescribing any controlled medication. One quirk: if you’re practicing in Florida via an out-of-state telehealth registration (rather than full Florida licensure), you cannot prescribe controlled substances remotely.

Texas allows telehealth prescribing of psychiatric medications, including controlled anxiolytics, as long as you establish a proper patient-provider relationship via live video. The state does ban telemedicine treatment of ‘chronic pain’ with controlled drugs — but anxiety treatment doesn’t fall into that category. You must query the Texas PDMP before prescribing Schedule II-IV medications. Texas is part of the Interstate Medical Licensure Compact (IMLC), which makes it easier to obtain licenses in multiple states if you want to expand your telehealth practice.

California has no special telehealth restrictions beyond federal requirements. You can prescribe anxiety medications, including benzos and stimulants for comorbid ADHD, entirely via video visits. California’s telehealth payment parity law (AB 744) ensures you get reimbursed equally for virtual visits, which makes the economics work. California does not participate in the IMLC, so you’ll need a full California license to treat patients there.

New York integrates telehealth seamlessly into standard psychiatric practice. No special prescribing limits for controlled substances. The catch: New York has one of the strictest PDMP mandates in the country (iSTOP) — you must check it for every controlled medication prescription, every time, with very few exceptions. This adds an extra step but ensures you’re practicing safely.

Pennsylvania and Illinois follow similar patterns: no telehealth-specific barriers to prescribing anxiety meds. Both require PDMP checks. Illinois has strong telehealth parity laws and Medicaid coverage. Pennsylvania is still working on comprehensive telehealth legislation, but in practice, psychiatrists can deliver medication management remotely following standard-of-care guidelines.

Bottom line for psychiatrists: You have wide latitude. Follow PDMP requirements, document your telehealth encounters properly, and stay updated on the DEA’s forthcoming permanent rules. The current environment is favorable for building or scaling a telepsychiatry practice focused on anxiety treatment.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNPs and Anxiety Prescribing: It Depends on Your State

This is where it gets more complicated — and where many nurse practitioners searching for answers get frustrated. Your ability to prescribe anxiety medications independently via telehealth depends entirely on which state you’re licensed in and whether you meet experience requirements.

Full Practice Authority States: Near-Parity with Psychiatrists

About half of U.S. states now grant nurse practitioners Full Practice Authority (FPA), meaning you can evaluate, diagnose, and prescribe medications — including controlled substances like benzodiazepines — without any physician supervision or collaborative agreement.

New York is the gold standard example. After the 2022 Nurse Practitioner Modernization Act, New York PMHNPs operate with complete independence. No written practice agreement required. No physician oversight. You can open your own practice, join a telehealth platform, and manage anxiety patients exactly as a psychiatrist would (aside from minor reimbursement differences we’ll cover below). If you’re prescribing controlled substances, you still need to check iSTOP, but there’s no physician sign-off requirement.

Arizona, Washington, Oregon — similar stories. FPA means you’re treating anxiety patients on equal footing with physicians in terms of legal authority.

Reduced/Restricted Practice States: Collaboration Required

The other half of states require PMHNPs to maintain a formal relationship with a physician to prescribe. This is where practice gets more constrained.

California is mid-transition. Historically one of the most restrictive states, California passed AB 890 in 2020, creating a pathway to independence. As of January 2023, experienced NPs can practice without physician-supervised protocols in certain group settings (103 NP certification). Starting January 2026, those same NPs can apply for full independent practice outside group settings (104 NP certification). If you’re a new PMHNP in California or haven’t met the experience thresholds, you still need a supervising physician and written standardized procedures to prescribe anxiety medications. The good news: California’s change means more PMHNPs will have independent authority soon.

Texas remains highly restrictive. You must have a Prescriptive Authority Agreement with a Texas physician to prescribe anything. The physician doesn’t co-sign every prescription in real time, but they supervise your practice with periodic chart reviews. Here’s the bigger constraint: Texas law prohibits NPs from prescribing Schedule II controlled substances in outpatient settings (with narrow exceptions for hospital patients or hospice care). For anxiety treatment, this means you can prescribe benzodiazepines (Schedule IV) if your collaborating physician authorizes it, but you cannot prescribe stimulants for comorbid ADHD unless you’re hospital-based. Texas has no pathway to independence legislatively as of 2026, so you’ll need that physician collaboration for your entire career there.

Florida also requires physician collaboration for PMHNPs. You must practice under a written protocol with a supervising physician. Florida has a special rule for controlled substances: NPs are generally limited to a 7-day supply of Schedule II prescriptions, unless you’re a psychiatric nurse practitioner prescribing psychiatric medications for a mental disorder. That exemption means you can prescribe benzodiazepines or other anxiety meds beyond the 7-day limit if you’re board-certified in psych and treating an anxiety disorder. The physician protocol still applies, but you have more flexibility than general NPs.

Pennsylvania requires a collaborative agreement for all NP practice and prescribing. The physician must countersign a percentage of your charts (often 100% for new patients and all Schedule II prescriptions). If you’re managing a patient’s SSRI, that’s straightforward. If you want to add a benzodiazepine, your collaborating psychiatrist needs to be comfortable with that and available for consultation. There’s ongoing legislative effort for FPA in Pennsylvania, but nothing has passed yet.

Illinois offers a middle ground. New NPs need a collaborative agreement, but once you’ve completed 4,000 hours of clinical practice and 250 hours of continuing education, you can apply for Full Practice Authority. Even with FPA, Illinois requires a one-time physician attestation for prescribing benzodiazepines or Schedule II narcotics — essentially, a physician acknowledges you’ll be prescribing those classes. After that, you can prescribe independently. For a PMHNP in Illinois, this means a few years of collaboration early in your career, then near-independence.

Controlled Substances: The Extra Layer

In all states, PMHNPs need a DEA registration to prescribe controlled anxiety medications. States differ on whether you can obtain that DEA license independently or need physician involvement.

In FPA states like New York or Arizona, you apply for your DEA as soon as you’re licensed — no physician sign-off needed. In restricted states like Texas, Florida, or Pennsylvania, you need an active collaboration or supervision agreement on file before the state will grant you controlled substance authority or approve your DEA application.

Schedule II restrictions (like Texas’s ban on NP outpatient prescribing of stimulants) don’t apply to most anxiety medications, since benzodiazepines are Schedule IV. But if you’re treating complex cases with comorbid ADHD or treatment-resistant depression that might involve a stimulant, those Schedule II limits will matter.

The Practical Impact

Here’s what this means if you’re a PMHNP considering telehealth anxiety work:

In New York, you can join Klarity or a similar platform and operate exactly like a psychiatrist — see patients, prescribe SSRIs, add Xanax if clinically appropriate, manage follow-ups, all remotely with no physician oversight.

In Texas, you need a local physician willing to sign a collaboration agreement (which may cost you money) and you’re limited in what you can prescribe for certain comorbid conditions. You also can’t operate purely remotely without that physician relationship in place.

In California, if you’ve hit the experience milestones and obtained 104 NP certification, you’re independent. If not, you’re still tethered to a supervising physician.

This isn’t just a legal technicality — it directly affects your ability to practice, earn income, and serve patients efficiently. Platforms like Klarity navigate these differences by ensuring NPs in restricted states are paired with physician collaborators when required, or by focusing recruitment in FPA states where the administrative burden is lower.

Reimbursement Reality: What You’ll Actually Earn for Anxiety Medication Management

Let’s talk about money, because understanding reimbursement helps you evaluate whether telehealth anxiety work makes economic sense.

Medicare Rates (The Benchmark)

Medicare pays surprisingly well for psychiatric medication management. Here are 2026 rates:

• Initial psychiatric evaluation (CPT 90792): ~$202
• 15-minute med check follow-up (99213): ~$95
• 25-minute moderate complexity visit (99214): ~$136
• 30-minute therapy add-on (90833): ~$81

If you’re doing pure medication management for anxiety patients (the 15-minute check-ins that are the backbone of outpatient psychiatry), you’re looking at roughly $95 per visit from Medicare. Medicare has extended telehealth payment parity through at least 2025, and practically through 2026, meaning virtual visits pay the same as in-person.

One Medicare wrinkle to watch: there was a proposed rule requiring an in-person visit within 6 months for tele-mental health services (and annually thereafter). Congress has delayed enforcement, but if it eventually takes effect, you might need to arrange occasional in-person encounters for Medicare patients. For now, it’s not an issue.

Medicaid: Lower Rates, Higher Volume

Medicaid pays significantly less — often 50-60% of Medicare rates. An initial psych eval might reimburse around $85 instead of $202. A med check follow-up could be $40-50 instead of $95.

The trade-off: Medicaid patient volume is high. Many people with anxiety disorders qualify for Medicaid, especially in expansion states. If you’re willing to accept lower per-visit rates, you can build a busy practice. Most states now reimburse Medicaid telehealth at parity with in-person, and states like Illinois and Pennsylvania have strong Medicaid tele-mental health coverage.

Commercial Insurance: Variable but Reasonable

Private insurers typically pay 100-150% of Medicare rates. You might get $100-$120 for a standard med check (99213). Many states have telehealth parity laws requiring insurers to cover and reimburse virtual visits equally. California (AB 744), Illinois, and New York all have strong parity provisions.

Some psychiatrists operate entirely out-of-network or cash-pay to avoid insurance hassles and charge $150-$250 per visit directly to patients. That’s a viable model in affluent markets, but it limits your patient pool. Most telehealth platforms credential you with insurers to maximize access and volume.

PMHNP vs Psychiatrist Reimbursement

Here’s the catch for nurse practitioners: Medicare and most insurers reimburse NPs at 85% of the physician fee schedule when you bill under your own NPI.

If a psychiatrist gets $100 for a visit, you get $85 for the exact same service. Some states’ Medicaid programs pay NPs equally to MDs, but many follow the 85% rule. This reimbursement gap is frustrating, but it’s reality.

Platforms and group practices sometimes use ‘incident-to’ billing (where your services are billed under a supervising physician’s NPI at 100% rate) to close this gap, but that requires strict conditions — the physician must be on-site and the patient must be established with a treatment plan already in place. In telehealth psychiatry, incident-to billing is rarely feasible. You’re typically billing under your own NPI at the 85% rate.

Why this matters economically: If you’re joining a telehealth platform as a PMHNP, your revenue per visit will be slightly lower than a psychiatrist’s. That’s partly why NP salaries are generally lower than MD salaries — but in high-volume settings, the difference can balance out.

The Platform Economics vs DIY Marketing

Here’s where providers often get confused about patient acquisition costs and revenue models.

The DIY reality: Building your own patient base through SEO, Google Ads, or directory listings like Psychology Today is expensive and time-consuming.

• SEO takes 6-12 months of consistent content and technical investment before generating meaningful patient flow
• Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert to booked patients. Realistically, you’re looking at $200-400+ cost per booked patient through PPC when you factor in ad spend, testing, optimization, and no-show rates
• Psychology Today and similar directories charge monthly fees ($30-50/month) and you’re competing with hundreds of other providers on the same page
• Zocdoc charges per booking ($35-100+ depending on specialty and market) PLUS monthly subscription fees
• When you add up agency/consultant fees, staff time to handle leads, failed campaigns, and months of investment before results, acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ all-in

Most solo providers don’t have the expertise, budget, or patience for this. You’re a clinician, not a digital marketer.

The Klarity model: Klarity (and similar platforms) uses a pay-per-appointment model. You pay a standard listing fee per new patient lead — similar to Zocdoc’s per-booking fee, but without the monthly subscription on top.

The value proposition:

• No upfront marketing spend — you’re not gambling $3,000-5,000/month on Google Ads hoping for results
• Pre-qualified patients already matched to your specialty, availability, and insurance
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure — no separate platform costs for video, EHR, scheduling
• Both insurance and cash-pay patient flow depending on your preference
• You control your schedule — only pay when you see patients

The economic logic: instead of spending thousands monthly on marketing with uncertain ROI, you pay only when a qualified patient books with you. That’s guaranteed ROI vs gambling on marketing channels you don’t control.

Is a platform right for everyone? No. If you have the capital, expertise, and patience to build your own patient funnel over 12-18 months, DIY can eventually be cost-effective. But for most providers — especially those starting out, scaling quickly, or practicing part-time alongside other work — a platform that handles patient acquisition removes the financial risk entirely.

Understanding the Compliance Landscape: PDMPs, Documentation, DEA Rules

Regardless of whether you’re a psychiatrist or PMHNP, practicing via telehealth or in-person, compliance is non-negotiable when prescribing anxiety medications (especially controlled substances).

PDMP Requirements

Every state now has a Prescription Drug Monitoring Program (PDMP) — a database tracking controlled substance prescriptions. State laws vary on when you must check it:

• New York (iSTOP): Check before every controlled prescription, every time, with narrow exceptions
• Florida (E-FORCSE): Check before prescribing any controlled substance
• Texas (PMP Aware): Check before initiating and periodically during treatment
• California, Pennsylvania, Illinois: Similar check requirements before initiating controlled substances and at intervals

PDMP checks take 30-60 seconds in most systems. They help you identify patients filling multiple benzos from different providers or combining controlled meds unsafely. Document that you checked in your note.

Documentation Standards

Whether your visit is via video or in-person, your documentation must support your medical decision-making. For anxiety medication management:

• Document presenting symptoms and severity
• Note any previous treatments and their outcomes
• Record side effects or adherence issues
• Explain your clinical reasoning for medication choices or adjustments
• For telehealth, note that the encounter was conducted via video and document patient consent for telehealth services

Many payers audit claims. Proper documentation ensures you can justify the level of service billed (99213 vs 99214, for example).

DEA Registration and Multi-State Practice

If you’re prescribing controlled substances in multiple states via telehealth, you need separate DEA registrations for each state where you’re seeing patients and prescribing controlled meds. A Texas DEA registration doesn’t allow you to prescribe to a Florida patient.

The Interstate Medical Licensure Compact (IMLC) makes it easier for physicians to obtain licenses in multiple states quickly. Texas, Illinois, and several others participate. Pennsylvania and New York don’t. California doesn’t participate either, so you’ll need to go through California’s full licensing process separately.

For NPs, there’s the Nurse Licensure Compact (NLC), which allows practice across participating states with a single multi-state license — but prescribing controlled substances still requires state-specific authorization in many cases, even if you hold a compact license.

Platforms like Klarity typically handle credentialing logistics and ensure you’re only seeing patients in states where you’re properly licensed and registered.

The Provider Shortage Context: Why Your Services Matter

If you’re wondering whether there’s demand for telehealth anxiety prescribers, the short answer is overwhelming yes.

Anxiety disorders are the most common mental health conditions in the U.S. The psychiatrist shortage is severe:

• Texas: One psychiatrist per ~8,966 residents (national average is closer to 1:5,000)
• Florida: Ratio of 1:8,577
• Illinois: 1:5,849
• Pennsylvania: 1:4,586, but rural areas meet only 31% of need
• New York: Better at 1:2,913, but still gaps in underserved areas

These shortages, combined with rising anxiety rates post-pandemic, mean patients are waiting weeks or months for appointments. Telehealth expands access dramatically — a psychiatrist in New York can treat a patient in rural upstate without the patient traveling hours for a 15-minute med check.

For PMHNPs, the demand is even higher. You’re often the only prescriber available in rural or underserved areas. States with restrictive scope-of-practice laws (like Texas) are ironically the ones with the worst shortages, because they limit how NPs can practice independently.

Joining a telehealth platform allows you to serve patients across state lines (where you’re licensed), fill gaps in care, and build a sustainable practice without the overhead and risk of traditional solo practice.

Frequently Asked Questions

Can psychiatrists prescribe benzodiazepines via telehealth?

Yes. As of 2026, federal telehealth flexibilities allow psychiatrists to prescribe controlled substances including benzodiazepines (Schedule IV) without an initial in-person visit. This extension runs through December 2026. You must comply with state PDMP requirements and document your clinical reasoning, but there’s no federal barrier to prescribing Xanax, Klonopin, or Ativan via video visit.

Can PMHNPs prescribe anxiety medication independently?

It depends on your state. In Full Practice Authority states like New York, Arizona, Washington, and Oregon, yes — you can prescribe anxiety medications including controlled substances independently. In states requiring physician collaboration (Texas, Florida, Pennsylvania, and others), you need a formal agreement with a supervising physician. California is transitioning to independence for experienced NPs (104 NP certification as of 2026). Illinois allows independence after 4,000 hours and additional education.

Do Medicare and private insurance pay the same for telehealth as in-person?

For psychiatric services, yes — currently. Medicare’s telehealth payment parity has been extended through 2025 and practically into 2026. Many states have enacted permanent telehealth parity laws requiring private insurers to reimburse virtual visits equally to in-person visits (California, Illinois, New York, and others). Texas does not mandate parity by law, but many insurers voluntarily pay equally for tele-mental health services.

What’s the difference between a psychiatrist and PMHNP for anxiety treatment?

Clinically, both can diagnose anxiety disorders and prescribe medications. The differences:

Training: Psychiatrists have 4 years of medical school + 4 years of residency (8+ years post-college). PMHNPs typically have 2-3 years of graduate training in psychiatric nursing.

Scope: Psychiatrists can practice independently in all states and prescribe any medication. PMHNPs’ authority varies by state — some practice independently, others require physician collaboration.

Reimbursement: Medicare and most insurers pay NPs at 85% of physician rates when billing under their own NPI.

Outcomes: Research shows PMHNPs provide effective medication management for anxiety and depression with similar patient outcomes as psychiatrists for routine cases. Many psychiatrists and PMHNPs work in collaborative teams.

How much does patient acquisition cost if I market my practice myself?

Realistically, $200-500+ per qualified patient when you factor in all costs:

• Google Ads: $15-40+ per click, with conversion rates meaning $200-400+ per booked patient
• SEO: 6-12 months of investment before meaningful results, requiring ongoing content and technical work
• Psychology Today/Zocdoc: Monthly subscription fees ($30-100+) plus per-booking charges, plus competition with hundreds of providers
• Staff time to handle and qualify leads
• No-show rates from cold leads
• Failed campaigns and testing costs

Most providers underestimate the true all-in cost because they don’t track their time or failed experiments. A platform like Klarity removes this risk by using a pay-per-appointment model — you only pay when a pre-qualified patient books with you.

Can I prescribe across state lines via telehealth?

Only in states where you hold an active medical or nursing license and DEA registration (if prescribing controlled substances). You cannot treat a Texas patient with only a New York license, even if the visit is virtual. The Interstate Medical Licensure Compact (IMLC) makes multi-state licensing easier for physicians in participating states. For NPs, the Nurse Licensure Compact (NLC) allows practice in participating states, but prescribing authority often requires state-specific approval.

What happens when the DEA’s temporary telehealth rules expire?

The current telehealth flexibilities allowing controlled substance prescribing without an initial in-person visit run through December 2026. The DEA is developing permanent regulations expected by late 2026. These will likely include some form of special telemedicine prescribing registration or modified exam requirements, but the goal is to preserve access to virtual mental health care. Stay updated through the DEA and HHS websites, and work with platforms that monitor regulatory changes.

The Bottom Line: Telehealth Anxiety Prescribing Is Viable and Growing

Whether you’re a psychiatrist looking to expand into telehealth or a PMHNP navigating state practice laws, the current environment supports building a robust anxiety treatment practice online.

For psychiatrists: You have full authority, favorable reimbursement, and regulatory flexibility through at least 2026. The main variables are state licensing (which you can expand through IMLC) and PDMP compliance.

For PMHNPs: Your autonomy depends heavily on your state, but the trend is toward greater independence. If you’re in or can get licensed in an FPA state, telehealth opens significant opportunities. If you’re in a restricted state, finding the right physician collaborator (or working with a platform that provides that) is key.

For both: The economics of telehealth are compelling when you compare platform models to DIY marketing. No upfront risk, pre-qualified patients, built-in infrastructure, and pay-per-appointment pricing means you can focus on clinical work instead of becoming a marketing expert.

The provider shortage is real. Patients need you. Telehealth makes it possible to serve them efficiently, compliantly, and profitably.

Ready to start seeing anxiety patients on a platform that handles licensing, credentialing, marketing, and infrastructure? Explore how Klarity’s provider network works and whether it’s the right fit for your practice goals. No upfront costs. No marketing gambles. Just patients who need your expertise.

Sources and References

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (Official .gov, Jan 2, 2026) – Federal government source confirming extension of telehealth controlled substance prescribing rules through December 2026.

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (Official state .gov, 2024 Statutes) – State law text defining PMHNP scope of practice, controlled substance prescribing limits, and telehealth rules specific to psychiatric treatment in Florida.

3. California Board of Registered Nursing – AB 890 Implementation FAQs (Official state board, Updated 2024) – State regulatory guidance on new NP independent practice categories (103 NP and 104 NP certifications) taking effect 2023-2026.

4. NPNY announcement – ‘NP Modernization Act Passes in NY’ (Professional Association Blog, Apr 9, 2022) – Documents New York’s transition to full practice authority for nurse practitioners, eliminating collaborative agreement requirements.

5. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (Industry/Professional Blog, 2025 rates for 2026) – Aggregates CMS Medicare fee schedule data for psychiatric billing codes including CPT 90792, 99213, 99214, and psychotherapy add-ons.

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs